They evacuated an AstraZeneca vaccine factory to …

Nail industrial factory in Wales, where the doses of vaccine developped by Oxford University and the laboratory AstraZeneca, was expelled on Wednesday after receiving a bomb alert. The incident took place at the premises of Wockhardt UK Limited, located outside the town of Wrexham, 40 kilometers south of Liverpool. Meanwhile, the European Union has a discussion with AstraZeneca about the delay in the delivery of doses.

According to Wockhardt in a statement, the industrial complex received a suspicious packageConsequently, the local authorities “ordered the partial evacuation of the property on the basis of the recommendation of experts”. Currently, they argued, they are “pending a full investigation.”

At the site, local media detailed, there was a deployment of explosives handling experts equipped with a special robot to perform their task. During the operation, the local police also ordered the streets to be closed and asked the population “to avoid the area until further notice”.

Mark Drakeford, the Welsh Prime Minister, said he was working with security forces to investigate the threat to the UK’s Wockhardt plant, which was visited in November by Prime Minister Boris Johnson, posing for photographers with blisters from the AstraZeneca vaccine before it was received. the regulatory green light from the British health authorities.

Tension between the European Union and AstraZeneca

Wockhardt UK Limited signed a contract in August to help prepare the Oxford-AstraZeneca vaccine. Hours before the bomb threat, a rumor spread that AstraZeneca executives had withdrawn from a meeting with European Union officials. to those who have had to explain the delays in the supply of vaccines against the coronavirus. However, the company denied leaving the meeting and said it would continue talks later today.

The controversy between European Union and AstraZeneca exploded on Friday, after the lab announced that could reduce its vaccine delivery schedule to the EU due to production chain issues in one of its factories located on European territory. However, this situation did not affect the United Kingdom – where the company has set up two production plants – which has maintained the pace of supply.

European Health Commissioner Stella Kyriakides told a press conference that UK’s two AstraZeneca factories set to supply vaccines to meet EU commitments. “I want it to be crystal clear: there is no hierarchy between these factories in the contract, there are no differences between factories in the UK and those in the EU, ”Kyriakides said.

For the official, “the British factories are part of the advance purchase contract, and that is why these factories must provide the vaccines.”